摘要
目的探讨疾病诊断相关分组(DRGs)付费模式对消化内科抗菌药物和质子泵抑制剂应用合理性的影响。方法回顾性选取广西壮族自治区玉林市第二人民医院消化内科2020年3月至2022年3月收治的患者500例,按是否采用DRGs付费模式分为DRGs组(257例)和常规组(243例),比较两组患者抗菌药物和质子泵抑制剂的用药强度、药品费用占比、药物利用指数、平均住院天数、使用率、不合理用药发生率。结果DRGs组的抗菌药物和质子泵抑制剂的不合理用药发生率为6.61%,显著低于常规组的14.40%(P<0.05);治疗总费用、平均住院天数均显著低于常规组(P<0.05);用药强度、药品费用占比、使用率均显著低于常规组(P<0.05);药物利用指数显著高于常规组(P<0.05)。结论DRGs付费模式下该院消化内科抗菌药物和质子泵抑制剂的应用合理性均有效提升,有助于降低药品费用占比,减少不合理用药。
Objective To investigate the influence of diagnosis-related grouping(DRGs)payment models on the application rationality of antibiotics and proton pump inhibitors(PPIs)in the Department of Gastroenterology.Methods A total of 500 patients admitted to the Department of Gastroenterology in the Yulin Second People's Hospital from March 2020 to March 2022 were retrospectively selected and divided into the DRGs group and the conventional group according to whether the DRGs payment mode was adopted.The use density,proportion of drug costs,drug utilization index(DUI),average length of stay,usage rate,and irrational use of antibiotics and PPIs were compared between the two groups.Results The incidence of irrational use of antibiotics and PPIs in the DRGs group was 6.61%,which was significantly lower than 14.40%in the conventional group(P<0.05).The total treatment cost and the average length of stay in the DRGs group were significantly lower than those in the conventional group(P<0.05).The use density,proportion of drug costs,and usage rate in the DRGs group were significantly lower than those in the conventional group(P<0.05).The DUI in the DRGs group was significantly higher than that in the conventional group(P<0.05).Conclusion Under the DRGs payment model,the application rationality of antibiotics and PPIs in the Department of Gastroenterology in the hospital has been effectively improved,which plays a positive role in reducing the proportion of drug costs and reducing irrational drug use.
作者
韦凤
胡稀
杨省
高育华
陈世奇
WEI Feng;HU Xi;YANG Sheng;GAO Yuhua;CHEN Shiqi(Yulin Second People′s Hospital,Yulin,Guangxi,China 537000;Beiliu City People′s Hospital,Yulin,Guangxi,China 537400)
出处
《中国药业》
CAS
2023年第13期34-36,共3页
China Pharmaceuticals
基金
广西壮族自治区卫生健康委员会自筹经费科研项目[Z20211633]。
